
Brag House Holdings, Inc. Files Form 10-K and Reaffirms Strategic Vision for Gen Z Engagement Through Gaming
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH) ('Brag House' or the 'Company'), a media-tech company at the intersection of gaming, college sports, and digital brand engagement, today announced the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.
The Company reaffirmed its confidence in the execution of its strategic plan to redefine digital engagement for casual college gamers and brands seeking to connect with the Gen Z demographic. As outlined in the Management's Discussion and Analysis of its Annual Report on Form 10-K, Brag House continues to develop a first-of-its-kind digital platform where casual college gamers can compete, support their schools, engage in spirited banter, and win prizes in a safe, inclusive environment.
'We are creating more than a platform—we are building a new sports medium,' said Lavell Juan Malloy II, CEO and Co-Founder of Brag House. 'By merging gameplay with school spirit, our student-led tournaments, proprietary Bragging Functionality, and interactive experiences offer Gen Z an entirely new way to engage with college rivalries.'
The Company highlighted its landmark strategic partnership with Learfield, which launched in April 2025 in collaboration with Florida Gators Athletics. The partnership represents a significant revenue-generating opportunity and marks the first step in a nationwide rollout designed to scale across Learfield's network of over 200 collegiate institutions.
The Company reaffirmed its strategic focus by highlighting the launch of a landmark initiative with Florida Gators Athletics and Learfield's Florida Gators Sports Properties, as announced in its April 28, 2025 press release titled 'Brag House, Florida Gators Athletics, and Learfield Announce Strategic Partnership to Create New Digital Sports Medium for Gen Z.' This innovative collaboration introduces a new digital sports medium for Gen Z—merging school spirit, gaming, and live sports into immersive experiences, as detailed below.
The debut activation, known as the Brag Gator Gauntlet, kicks off in May 2025 at the University of Florida. This flagship series introduces:
By uniting Brag House's gamified platform with Learfield's nationwide network of collegiate institutions, this initiative redefines how fans and students engage with college sports. It also opens up high-impact, measurable opportunities for brands to reach Gen Z through student-led tournaments, influencer-driven campaigns, and serialized content. The Company believes this model will generate high-ROI advertising opportunities and serve as a foundation for future data-driven insights, enabling brands to engage Gen Z with greater precision, authenticity, and scale.
'Our development and marketing strategy is laser-focused on high-impact, revenue-producing milestones,' added Malloy. 'We are investing strategically in infrastructure while maintaining disciplined cost controls expected of a public company.'
The Company's near-term strategic goals include:
Brag House remains confident in its long-term growth trajectory and will continue providing shareholders with updates as key milestones are reached.
About Brag House
Brag House is a leading media technology gaming platform dedicated to transforming casual college gaming into a vibrant, community-driven experience. By seamlessly merging gaming, social interaction, and cutting-edge technology, the Company provides an inclusive and engaging environment for casual gamers while enabling brands to authentically connect with the influential Gen Z demographic. The platform offers live-streaming capabilities, gamification features, and custom tournament services, fostering meaningful engagement between users and brands. For more information, please visit www.braghouse.com.
Forward-Looking Statements
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release, include, but are not limited to statements relating to the ability to generate revenue from strategic partnership with Learfield; the ability to generate any revenue, return on investment, or any specific outcomes related to scheduled or unscheduled activations or immersive experiences; the ability to deliver anticipated platform growth, including through anticipated development roadmap or scalable model; the timeliness of any anticipated beta versions; the ability to generate revenue from anonymized behavioral insights or other proprietary data; the effectiveness of marketing strategies and strategic investments on revenue; the availability or value of any digital rewards and functionality; the feasibility of near-term strategic goals; or the impact on growth of near or long-term trajectories. In some cases, you can identify forward-looking statements because they contain words such as 'may,' 'will,' 'would,' 'should,' 'expects,' 'plans,' 'could,' 'intends,' 'target,' 'projects,' 'forecasts,' 'believes,' 'estimates,' 'anticipates,' 'potential,' 'continue,' 'assumption' or 'judgment' or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements.
Although the Company believes the expectations reflected in the forward-looking statements are reasonable when made, the Company cannot guarantee future results, levels of activity, performance, or achievements. There are a number of important factors that could cause the Company's actual results to differ materially from the results anticipated by the Company's forward-looking statements, which include, but are not limited to: the Company's history of recurring losses and anticipated expenditures raises substantial doubts about its ability to continue as a going concern; the Company's loss of or a substantial reduction in activity by one or more of its largest clients, vendors and/or sponsors could materially and adversely affect its business, financial condition and results of operations; the Company's revenue model may not remain effective, and the Company cannot guarantee that its future monetization strategies will be successfully implemented or generate sustainable revenues and profit; technology changes rapidly in the Company's business and if it fails to anticipate or successfully implement new technologies or adopt new business strategies, technologies or methods, the quality, timeliness and competitiveness of the Company's amateur tournaments or competitions may suffer; the Company relies on information technology and other systems and platforms, and any failures, errors, defects or disruptions in the Company's systems or platforms could diminish its brand and reputation, subject it to liability, disrupt its business, affect its ability to scale its technical infrastructure and adversely affect its operating results and growth prospects..
Additional factors include those described in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, including under the captions 'Risk Factors,' 'Management's Discussion and Analysis of Financial Condition and Results of Operations,' and 'Business,' in the Company's subsequent quarterly reports on Form 10-Q, including under the captions 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations,' and in our subsequent filings with the Securities and Exchange Commission.
A forward-looking statement is neither a prediction nor a guarantee of future events or circumstances. You should not place undue reliance on the forward-looking statements. Unless required by federal securities laws, the Company assumes no obligation to update any of these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated, to reflect circumstances or events that occur after the statements are made.
Investor Relations Contact:
Adele Carey
VP, Investor Relations
[email protected]
Media Contact:
Fatema Bhabrawala
Director of Media Relations
[email protected]
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics ('Gyre') (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today announced that the first volunteer has been successfully dosed in a Phase 1 clinical trial evaluating F230, a novel endothelin A ('ETA') receptor antagonist, for the treatment of pulmonary arterial hypertension ('PAH').This milestone marks Gyre's entry into the PAH field, a rare, progressive, and high-mortality cardiovascular condition with limited treatment options. PAH is recognized in China's National Rare Disease Catalog, underscoring its significance in public health. According to Frost & Sullivan, China's PAH market was valued at $370 million in 2023 and is projected to grow to $480 million by 2031.F230, originally discovered by Eisai Co., Ltd. and exclusively licensed by GNI Group Ltd. to Gyre, is a fully synthetic small molecule designed to selectively block the ETA receptor. By targeting this pathway, F230 is designed to reduce pulmonary vascular remodeling and lower pulmonary pressure, key contributors to PAH Phase 1 trial is designed to evaluate safety, tolerability, and pharmacokinetics in healthy volunteers. The trial represents the latest expansion of Gyre's fibrosis-first strategy beyond the liver, leveraging a robust clinical development platform and commercial infrastructure in China.F230 joins Gyre's pipeline alongside lead candidate Hydronidone (F351), which met the primary endpoint in a pivotal Phase 3 trial for CHB-fibrosis. A New Drug Application ('NDA') submission to China's National Medical Products Administration ('NMPA') is planned for the third quarter of 2025, and a pre-IND meeting with the U.S. Food and Drug Administration is being planned for an expected Phase 2 trial in metabolic dysfunction-associated steatohepatitis ('MASH') Gyre TherapeuticsGyre Therapeutics is a biopharmaceutical company headquartered in San Diego, CA, primarily focused on the development and commercialization of Hydronidone for liver fibrosis, including MASH, in the U.S. Gyre's strategy builds on its experience in mechanistic studies using MASH rodent models and clinical studies in CHB-induced liver fibrosis. In the People's Republic of China, Gyre is advancing a broad pipeline through its indirect controlling interest in Gyre Pharmaceuticals, including therapeutic expansions of ETUARY, and development programs for F573, F528, and StatementsThis press release contains 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the Private Securities Litigation Reform Act of 1995, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this press release, are forward-looking statements, including statements concerning the expectations regarding Gyre's research and development efforts and timing of expected clinical trials, including an NDA submission to the NMPA for F351, the expected clinical benefits of F230 and expectations regarding interactions with regulators. In some cases, you can identify forward-looking statements by terms such as 'may,' 'might,' 'will,' 'objective,' 'intend,' 'should,' 'could,' 'can,' 'would,' 'expect,' 'believe,' 'design,' 'estimate,' 'predict,' 'potential,' 'plan' or the negative of these terms, and similar expressions intended to identify forward-looking statements. These statements reflect our plans, estimates, and expectations, as of the date of this press release. These statements involve known and unknown risks, uncertainties and other factors that could cause our actual results to differ materially from the forward-looking statements expressed or implied in this press release. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation: Gyre's ability to execute on its clinical development strategies; positive results from a clinical trial may not necessarily be predictive of the results of future or ongoing clinical trials; the timing or likelihood of regulatory filings and approvals; competition from competing products; the impact of general economic, health, industrial or political conditions in the United States or internationally; the sufficiency of Gyre's capital resources and its ability to raise additional capital. Additional risks and factors are identified under 'Risk Factors' in Gyre's Annual Report on Form 10-K for the year ended December 31, 2024 filed on March 17, 2025 and in other filings Gyre may make with the SEC. Gyre expressly disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by Contact:David ZhangGyre in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
Serial Entrepreneur Cameron Forni Brings Adaptaphoria to Benzinga Capital Conference with Exclusive Tastings and Industry Panel
Reputation Pros Highlights Serial Entrepreneur Cameron Forni Brings Adaptaphoria to Benzinga Capital Conference with Exclusive Tastings and Industry Panel Chicago, June 10, 2025 (GLOBE NEWSWIRE) --Reputation Pros is pleased to highlight ADAPTAPHORIA, the new hemp-infused functional beverage brand from modern socializer and cannabis pioneer Cameron Forni, is making a bold debut at the Benzinga Capital Conference in Chicago. The brand will feature live tastings on the show floor and host an exclusive, VIP invite-only dinner pairing its beverages with a curated cannabis-infused menu. Forni will also speak on a high-impact industry panel exploring the future of cannabis beverage distribution. As Adaptaphoria steps into the spotlight, it brings with it a powerful mission: to revolutionize social drinking through plant-based beverages that enhance energy or relaxation. The brand's debut collection—Energize and Unwind—blends adaptogens, botanicals, and hemp-based cannabinoids to offer an intentional, alcohol-free alternative for today's health-conscious and sober-curious consumers. 'Adaptaphoria is about elevating how we connect,' says founder Cameron Forni. 'Post-pandemic, we're facing a loneliness epidemic. People are looking for more meaningful connections, and we believe that social beverages should reflect that. We've created drinks that help people feel more present, without alcohol or sugar crashes.' At Benzinga, Adaptaphoria Will: Offer Live Tastings on the show floor, introducing attendees to its flavor-forward, effect-based beverages. Host an Exclusive VIP Dinner, pairing Adaptaphoria drinks with a gourmet cannabis-infused menu for select influencers, investors, and executives. Feature Cameron Forni on a Premier Industry Panel titled 'Supermarkets, Convenience Stores, Delivery, or Dispensaries: Who Will Own the Cannabis Beverage Consumer?' alongside leaders from Iconic Tonics, Daisy Labs, Franny's Farmacy, and TradeWorks. The panel will explore where the cannabis beverage market is heading as retailers like DoorDash and Total Wine enter the space. 'Consumer preferences are shifting—Gen Z is rejecting alcohol and artificial ingredients. With Select, I built a category-defining brand grounded in quality, and with Adaptaphoria, I'm applying the same discipline to a new wave of conscious consumption,' adds Forni. 'We're the first high-functional beverage with just 3 grams of sugar, only 15 calories, and a 5-minute onset,' he continues. 'The real marvel is achieving a rapid emulsion without any weed flavor or bitterness. We're sampling at Benzinga with industry tastemakers, and everyone's saying it's delicious!' says founder Cameron ForniFlavor and Function Energize Dragon Fruit and Black Berry Cola: Features Rhodiola Rosea, Guarana, Vitamin B12, and AstraGin® for stamina and focus. Unwind White Peach and Chill Berry: Crafted with KSM-66 Ashwagandha®, Passion Flower, and GABA to soothe and center. With intentional ingredients and refined flavor profiles, Adaptaphoria complements modern rituals—whether at happy hour, at home, or on the Praise 'We're thrilled to be part of the Adaptaphoria launch at the Benzinga Capital Conference,' says Eugenio Garcia, CEO of Cannabis Now. 'It's always a proud moment to introduce a revolutionary product to the cannabis industry. For those attending, this will be remembered as a milestone moment for cannabis beverages—and Adaptaphoria is leading the way as one of the highest-quality brands in the space.'About Adaptaphoria Adaptaphoria is a wellness-first brand creating functional, hemp-infused beverages designed to enhance everyday moments. Founded by Cameron Forni, the brand unites flavor, science, and lifestyle to create new standards in social drinking. Products are available nationwide at Follow Adaptaphoria on Social Media: Adaptaphoria Instagram Adaptaphoria Facebook Adaptaphoria TikTok Media Inquiries:press@ CONTACT: Reputation Pros Scott Keever contact@


Business Wire
27 minutes ago
- Business Wire
Leap and Xos Partner to Power the Grid with Electric Fleets
SAN FRANCISCO & LOS ANGELES--(BUSINESS WIRE)-- Leap, the leading platform for building and scaling virtual power plants (VPPs), and Xos, Inc., (NASDAQ:XOS), a leading electric truck manufacturer and fleet services provider, today announced a new partnership to unlock grid revenue opportunities for electrified fleets. By connecting Xos Hub charging technology to energy markets through Leap's automated platform, the companies will create new value for fleet owners and deliver crucial support for the grid during energy emergencies. By connecting Xos Hub charging technology to energy markets through Leap's automated platform, the companies will create new value for fleet owners and deliver crucial support for the grid during energy emergencies. Share Xos manufactures electric stepvan vehicles used by some of the country's most recognizable logistics companies, including FedEx and UPS. The company's Xos Hub is a mobile, battery-integrated charger designed to speed up fleet electrification without the delays or costs of traditional infrastructure. It provides a versatile, scalable solution for stopgap charging, remote deployments, semi-permanent charging, and backup power. Now, by using Leap's software-only VPP platform, Xos can enroll its customers in California's Demand Side Grid Support (DSGS) grid services program. During emergency grid events, participating fleets will automatically shift charging from the grid to their Xos Hub battery-integrating chargers, relieving grid strain while generating revenue. Last summer, with major contributions from Leap, DSGS helped California avoid blackouts during prolonged heatwaves. With the addition of Xos's rapidly growing portfolio, Leap and its partners are poised to scale their impact and deliver even greater support to the grid. 'Leveraging our complementary technologies, Leap and Xos are tapping new value streams for commercial truck fleets, the transportation services that power our economy,' said Jason Michaels, CEO of Leap. 'Together, we're making these fleets cleaner, smarter, and more cost effective, while contributing to a more resilient energy landscape.' Leap's universal API suite automates energy market operations, enabling Xos to quickly deploy and scale its own VPP offering without additional hardware or significant additional operational overhead. This means that Xos can immediately start generating new grid revenue, reducing the total product cost for customers and driving ongoing energy savings. 'Our VPP offering gives fleet customers advanced energy capabilities without compromising control or convenience,' said Dakota Semler, CEO of Xos, Inc. 'It's a powerful way to lower the cost of infrastructure ownership even further, maximize the value of our products, and support customers in meeting their electrification goals.' About Leap Leap is the leading platform for launching and scaling virtual power plants (VPPs). Through its software-only solution, Leap facilitates fast, easy and automated access to demand response and other grid services revenue streams for the providers of battery storage systems, EV chargers, smart building technologies, and other distributed energy resources (DERs). Managing over 200,000 energy sites and devices across U.S. energy markets, Leap empowers more than 90 technology partners and their customers to unlock new value and help create a more flexible, resilient grid powered by renewable resources. Visit to learn more. About Xos, Inc. Xos is a leading technology company, electric truck manufacturer, and fleet services provider for battery-electric fleets. Xos vehicles and fleet management software are purpose-built for medium- and heavy-duty commercial vehicles that travel on last-mile, back-to-base routes. The company leverages its proprietary technologies to provide commercial fleets with battery-electric vehicles that are easier to maintain and more cost-efficient on a total cost of ownership (TCO) basis than their internal combustion engine counterparts. For more information, visit